Chemistry: Catalyst developments for organic synthesis
Prof Masahiro Kamitani from the Department of Chemistry at Kitasato University, Japan, introduces recent advances in the development of catalysts for organic synthesis and iron catalysts as alternatives for precious metal catalysts.
New Pfizer Covid-19 pill seeking emergency use authorization from FDA
Pfizer have announced that it is seeking emergency use authorization for its new Covid-19 oral antiviral candidate PAXLOVID™
TIGRR: Is it a wonderful thing for the UK’s Cannabis Industry?
BCL Solicitors LLP ask if a new report should put a spring in the step of UK businesses with an interest in medicinal cannabis and cannabidiol (CBD).
The risks of anabolic steroids
Dr Deborah Lee, Dr Fox Online Pharmacy, explores the risks associated with anabolic steroids and how to get help if you have an addiction.
Fluvoxamine can cut COVID-19 hospitalisations by 30%
Fluvoxamine, a cheap repurposed drug, can cut COVID-19 hospitalisations by up to 30%, according to a new study.
New EU rules on veterinary medicines to support responsible use of antibiotics
Roxane Feller, AnimalhealthEurope Secretary-General, tells us all about the new EU rules on veterinary medicines to support more responsible use of antibiotics.
FDA approves Pfizer booster vaccine for over 65s
The U.S. Food and Drug Administration (FDA) has given authorisation for the Pfizer/BioNTech COVID-19 booster vaccine to be administered to people aged 65 and over.
CBD for arthritis: What the research shows
CBD has shown benefits for many health conditions, including arthritis. Here’s what the research shows.
The impact and importance of psychedelic medicine
Here, we discover the impact and importance of psychedelic medicine through the eyes of Amanda Feilding, Director of The Beckley Foundation.
The need for scientific research in sports medicine
Frost & Sullivan’s TechCasting Group, argues for increasing awareness of the need for scientific research in sports medicine.
The expanding scope of cannabinoids in epilepsy
Arun Swaminathan MD, Assistant Professor of Neurology and Epilepsy at the University of Nebraska Medical Center, details the expanding scope of cannabinoids in epilepsy.
Benchmarking Regulatory systems governing veterinary medicines – part 3
Rick Clayton, Technical Director, AnimalhealthEurope, in the final chapter of this three-part series, examines the benefits of benchmarking regulatory systems and promoting Good Regulatory Practice.
COVID-19: Challenges of vaccination logistics
The challenges of vaccination logistics during the COVID-19 pandemic are charted in this updated view, written by Zisis Kozlakidis and John Litaker.
High stakes: Is the UK finally clearing a pathway for cannabis investments?
John Binns, Partner at BCL Solicitors LLP says it’s high stakes when it comes to the UK finally clearing a pathway towards cannabis investments.
Cholesterol medication may reduce COVID-19 severity
Researchers have confirmed that statin medication lower the risk of in-hospital death from COVID-19, following a new study.
Ensuring regulatory compliance for Medical Cannabis
Here, Evolve Ltd’s Managing Director, Christopher Busuttil Delbridge, takes us progressively deeper into what it takes to ensure regulatory compliance for Medical Cannabis.
CBD oil for pain: What the research shows
Oils by Simpson of 2012 supplies organic full-spectrum CBD cannabis oil products. CBD oil is popular and commonly used for its potent therapeutic benefits, but what about its effect on pain? Here’s what the research shows.
Canvassing public awareness on veterinary medicines
Roxane Feller, Secretary General of AnimalhealthEurope, explains to us canvassing public awareness on the benefits of veterinary medicines.
Commission signs third contract for 1.8 billion BioNTech-Pfizer doses
The European Commission has announced that it has signed a third contract to secure an additional 1.8 billion BioNTech-Pfizer vaccine doses.
Logistics & supply chain will win the COVID-19 war
Professor Richard Wilding argues that biochemistry is winning the battle against coronavirus, but logistics and supply chain will win the war.
